Literature DB >> 22099770

Cellular immunoisolation for islet transplantation by a novel dual porosity electrospun membrane.

L Krishnan1, L R Clayton, E D Boland, R M Reed, J B Hoying, S K Williams.   

Abstract

Immunoisolation strategies have the potential to impact the treatment of several diseases, such as hemophilia, Parkinson's and endocrine disorders, such as parathryroid disorders and diabetes. The hallmark of these disease states is the amelioration of the disease process by replacement of the deficient protein. Naturally, several cellular therapeutic strategies like genetically modified host cells, stem cells, donor cells, or even complex tissues like pancreatic islets have been investigated. Current evidence suggests that successful strategies must incorporate considerations for local hypoxia, vascularity, and immunoisolation. Additional regulatory concerns also include safe localization of implanted therapeutic cells to allow for monitoring, dose adjustment, or removal when indicated. Local hypoxia and cellular toxicity can be detrimental to the survival of freshly implanted pancreatic islets, leading to a need for a larger initial number of islets or repeated implantation procedures. The lack of adequate donors and the large number of islet equivalents needed to achieve euglycemic states amplify the nature of this problem. We have developed a novel immunoisolation device based on electrospun nylon, primarily for islet transplantation, such that the inner component functions as a cellular barrier while allowing diffusion, whereas the outer component can be optimized for tissue integration and accelerated vascularization. Devices explanted after subcutaneous implantation in wild-type B6 mice after a period of 30 days show vascular elements in the outer layer of the electrospun device. The inner layer when intact functioned as an effective barrier to cellular infiltration. The preimplantation of such a device, with a relatively thin inner barrier membrane, will allow for adequate vascularization and reduce postimplantation hypoxia. This study demonstrates the feasibility of an electrospun isolation device that can be easily assembled, modified by varying the electrospinning parameters, and functionalized with surface-active molecules to accelerate vascularization.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22099770      PMCID: PMC3235334          DOI: 10.1016/j.transproceed.2011.10.031

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  19 in total

1.  Extrahepatic transplant sites for islet xenotransplantation.

Authors:  Juan L Contreras
Journal:  Xenotransplantation       Date:  2008 Mar-Apr       Impact factor: 3.907

2.  Permeability of filters used for immunoisolation.

Authors:  H Iwata; N Morikawa; Y Ikada
Journal:  Tissue Eng       Date:  1996

3.  Transport characterization of membranes for immunoisolation.

Authors:  K E Dionne; B M Cain; R H Li; W J Bell; E J Doherty; D H Rein; M J Lysaght; F T Gentile
Journal:  Biomaterials       Date:  1996-02       Impact factor: 12.479

4.  Time course of membrane microarchitecture-driven neovascularization.

Authors:  R F Padera; C K Colton
Journal:  Biomaterials       Date:  1996-02       Impact factor: 12.479

5.  Engineering the tissue which encapsulates subcutaneous implants. II. Plasma-tissue exchange properties.

Authors:  A A Sharkawy; B Klitzman; G A Truskey; W M Reichert
Journal:  J Biomed Mater Res       Date:  1998-06-15

6.  Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol.

Authors:  E A Ryan; J R Lakey; R V Rajotte; G S Korbutt; T Kin; S Imes; A Rabinovitch; J F Elliott; D Bigam; N M Kneteman; G L Warnock; I Larsen; A M Shapiro
Journal:  Diabetes       Date:  2001-04       Impact factor: 9.461

Review 7.  Allogeneic islet transplantation.

Authors:  Simona Marzorati; Antonello Pileggi; Camillo Ricordi
Journal:  Expert Opin Biol Ther       Date:  2007-11       Impact factor: 4.388

8.  Mechanisms of arterial graft healing. Rapid transmural capillary ingrowth provides a source of intimal endothelium and smooth muscle in porous PTFE prostheses.

Authors:  A W Clowes; T R Kirkman; M A Reidy
Journal:  Am J Pathol       Date:  1986-05       Impact factor: 4.307

9.  Protection of encapsulated human islets implanted without immunosuppression in patients with type I or type II diabetes and in nondiabetic control subjects.

Authors:  D W Scharp; C J Swanson; B J Olack; P P Latta; O D Hegre; E J Doherty; F T Gentile; K S Flavin; M F Ansara; P E Lacy
Journal:  Diabetes       Date:  1994-09       Impact factor: 9.461

10.  A nanoporous, transparent microcontainer for encapsulated islet therapy.

Authors:  Barjor Gimi; Joonbum Kwon; Andrey Kuznetsov; Behroze Vachha; Richard L Magin; Louis H Philipson; Jeong-Bong Lee
Journal:  J Diabetes Sci Technol       Date:  2009-03
View more
  3 in total

Review 1.  Type 1 diabetes and engineering enhanced islet transplantation.

Authors:  Abiramy Jeyagaran; Chuan-En Lu; Aline Zbinden; Andreas L Birkenfeld; Sara Y Brucker; Shannon L Layland
Journal:  Adv Drug Deliv Rev       Date:  2022-08-21       Impact factor: 17.873

2.  Vascularization and cellular isolation potential of a novel electrospun cell delivery vehicle.

Authors:  Laxminarayanan Krishnan; Jeremy Touroo; Robert Reed; Eugene Boland; James B Hoying; Stuart K Williams
Journal:  J Biomed Mater Res A       Date:  2013-08-10       Impact factor: 4.396

Review 3.  Membranes to achieve immunoprotection of transplanted islets.

Authors:  Julien Schweicher; Crystal Nyitray; Tejal A Desai
Journal:  Front Biosci (Landmark Ed)       Date:  2014-01-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.